# BioMarin's Q1: Mixed Results, Upgraded Guidance

Page: https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/biomarin-s-q1-mixed-results-upgraded-guidance
Text version: https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/biomarin-s-q1-mixed-results-upgraded-guidance.md
Podcast: [Business News Today | 2 Min News | The Daily News Now!](https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192)
Published: 2026-05-14T01:01:42+00:00
Episode link: https://api.fastcast.ai/audio/3d485ea9-9e1a-47e8-a40f-037e1f1fcddd.mp3
Audio file: https://api.fastcast.ai/audio/3d485ea9-9e1a-47e8-a40f-037e1f1fcddd.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/biomarin-s-q1-mixed-results-upgraded-guidance
Duration seconds: 108

## Resource

BioMarin Pharmaceuticals Q1 earnings missed expectations with revenue at $766.2M, up 2.8% YoY but short of $776M forecast, and adjusted EPS at $0.76, missing $0.91 estimate due to manufacturing issues and Amicus acquisition costs. Margins dropped to 16.9% from 30% last year. The company raised full-year revenue guidance to $3.88B, up 14.8% from before, but trimmed adjusted EPS to $4.95. Theyre focusing on Amicus integration, new drugs, and clinical data for upcoming products. Margin recovery and regulatory moves could drive stock momentum. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/ad7d7e64420f3557

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/biomarin-s-q1-mixed-results-upgraded-guidance/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/biomarin-s-q1-mixed-results-upgraded-guidance.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.